UBS Group
NEOG icon

UBS Group’s Neogen NEOG Stock Holding History

UBS Group’s Portfolio NEOG Stock Details NEOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,333
Closed -$23K – 8721
2015
Q1 		$23K Sell
1,333
-1,334
-50% -$24.4K ﹤0.01% 6852
2014
Q4 		$50K Buy
+2,667
New +$43.9K ﹤0.01% 6483

Other funds holding NEOG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

UBS Group's NEOG Position: Q1 2026 in Review

UBS Group reduced its Neogen (NEOG) stake by 7.9% in Q1 2026, selling an estimated $1.28M and leaving 1,512,464 shares worth $14.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

UBS Group first reported a position in NEOG in Q4 2014 and has held it in 46 quarters since. The position peaked at $42.9M in Q4 2024. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • UBS Group held 1,512,464 shares of Neogen worth $14.1M as of Q1 2026.
  • UBS Group sold 129,707 Neogen shares in Q1 2026, an estimated $1.28M.
  • Neogen made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2985 holding.
  • UBS Group first reported a position in Neogen in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Neogen position peaked at $42.9M in Q4 2024.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.